Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects

Area of Science:

• Immunology
• Transfusion Medicine

Background:

• Human Leukocyte Antigen (HLA) class I molecules are crucial in immune responses.
• Their presence and quantity on erythrocytes (red blood cells) are not fully understood.
• Understanding red cell HLA is important for transfusion practices and preventing immune sensitization.

Purpose of the Study:

• To quantify Human Leukocyte Antigen (HLA) class I molecules on erythrocytes.
• To assess the significance of red cell HLA in blood transfusions.
• To evaluate the efficacy of transfusing blood with reduced red cell HLA in preventing patient sensitization.

Main Methods:

• Utilized a competitive binding assay with 125I-labeled Fab fragments of the anti-HLA monoclonal antibody W6/32.
• Established assay conditions using red cells with known high HLA expression via flow cytometry.
• Employed Scatchard analysis to determine the number of HLA molecules per red blood cell.

Main Results:

• Quantified approximately 1684 +/- 39 HLA molecules per red blood cell in individuals with high expression.
• Detected 100-200 HLA molecules per red blood cell in individuals with undetectable levels by flow cytometry.
• Found that transfusing blood with low red cell HLA did not significantly reduce sensitizing effects compared to regular transfusions.

Conclusions:

• Erythrocyte-bound HLA class I molecules, though fewer than on leukocytes, contribute significantly to the total antigenic load in blood transfusions.
• Current methods for reducing red cell HLA in transfusions are insufficient to prevent HLA sensitization in at-risk patients.
• Further strategies are needed to mitigate HLA-related immune responses in transfusion recipients.